Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC35G1 mRNA] | CTD | PMID:31150632 | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of SLC35G1 mRNA | CTD | PMID:23649840 | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC35G1 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SLC35G1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of SLC35G1 mRNA | CTD | PMID:32145629 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC35G1 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC35G1 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slc35g1 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC35G1 mRNA | CTD | PMID:25975270 | 3,7-dihydropurine-6-thione | decreases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of SLC35G1 mRNA | CTD | PMID:23358152 | 3-chloropropane-1,2-diol | decreases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of SLC35G1 mRNA | CTD | PMID:28522335 | 4-hydroxyphenyl retinamide | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SLC35G1 mRNA | CTD | PMID:28973697 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SLC35G1 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of SLC35G1 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of SLC35G1 mRNA | CTD | PMID:30047161 | afimoxifene | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | afimoxifene results in increased expression of SLC35G1 mRNA | CTD | PMID:26879975 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SLC35G1 mRNA | CTD | PMID:21934132 | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of SLC35G1 mRNA | CTD | PMID:26705709 | benzo[a]pyrene | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLC35G1 mRNA | CTD | PMID:21569818 | bisphenol A | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SLC35G1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC35G1 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of SLC35G1 gene | CTD | PMID:28505145 | bortezomib | decreases expression | EXP | | 6480464 | Bortezomib results in decreased expression of SLC35G1 mRNA | CTD | PMID:20977926 | bromobenzene | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | bromobenzene results in increased expression of SLC35G1 mRNA | CTD | PMID:32479839 | carbon nanotube | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLC35G1 gene] | CTD | PMID:28238834 | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC35G1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC35G1 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SLC35G1 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of SLC35G1 mRNA | CTD | PMID:19770486 | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of SLC35G1 mRNA | CTD | PMID:26705709 | dibutyl phthalate | decreases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of SLC35G1 mRNA | CTD | PMID:21266533 | dichloroacetic acid | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of SLC35G1 mRNA | CTD | PMID:28962523 | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of SLC35G1 mRNA | CTD | PMID:26516004 | dioxygen | multiple interactions | ISO | Slc35g1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC35G1 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of SLC35G1 mRNA | CTD | PMID:23649840 | fluoranthene | multiple interactions | ISO | Slc35g1 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of SLC35G1 mRNA | CTD | PMID:28329830 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of SLC35G1 mRNA | CTD | PMID:23649840 | genistein | decreases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Genistein results in decreased expression of SLC35G1 mRNA | CTD | PMID:32186404 | indole-3-methanol | affects expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | indole-3-carbinol affects the expression of SLC35G1 mRNA | CTD | PMID:21396975 | mercaptopurine | decreases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of SLC35G1 mRNA | CTD | PMID:23358152 | methimazole | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of SLC35G1 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of SLC35G1 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of SLC35G1 mRNA | CTD | PMID:28001369 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of SLC35G1 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | multiple interactions | ISO | Slc35g1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC35G1 mRNA | CTD | PMID:34911549 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SLC35G1 mRNA | CTD | PMID:29067470 | paracetamol | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of SLC35G1 mRNA | CTD | PMID:32479839 and PMID:33387578 | phenobarbital | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of SLC35G1 mRNA | CTD | PMID:19270015 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of SLC35G1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC35G1 mRNA | CTD | PMID:27188386 | pirinixic acid | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SLC35G1 mRNA | CTD | PMID:18301758 and PMID:23811191 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC35G1 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of SLC35G1 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of SLC35G1 mRNA | CTD | PMID:28903501 | progesterone | decreases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Progesterone results in decreased expression of SLC35G1 mRNA | CTD | PMID:22238285 | propiconazole | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | propiconazole results in increased expression of SLC35G1 mRNA | CTD | PMID:21278054 | purine-6-thiol | decreases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of SLC35G1 mRNA | CTD | PMID:23358152 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Silver results in increased expression of SLC35G1 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Silver results in increased expression of SLC35G1 mRNA | CTD | PMID:27131904 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SLC35G1 mRNA | CTD | PMID:28595984 | sodium arsenite | decreases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SLC35G1 mRNA | CTD | PMID:37682722 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of SLC35G1 mRNA | CTD | PMID:31533062 | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of SLC35G1 mRNA | CTD | PMID:31863870 | tetrachloroethene | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of SLC35G1 mRNA | CTD | PMID:28973375 | tetrachloromethane | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of SLC35G1 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC35G1 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SLC35G1 mRNA | CTD | PMID:34492290 | trichloroethene | increases expression | ISO | Slc35g1 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of SLC35G1 mRNA | CTD | PMID:25549359 | trichloroethene | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of SLC35G1 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of SLC35G1 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC35G1 mRNA | CTD | PMID:27188386 | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of SLC35G1 mRNA | CTD | PMID:29453283 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of SLC35G1 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SLC35G1 mRNA | CTD | PMID:23179753 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC35G1 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SLC35G1 mRNA | CTD | PMID:24383497 and PMID:26272509 | vinclozolin | increases expression | ISO | Slc35g1 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of SLC35G1 mRNA | CTD | PMID:22570695 and PMID:23034163 | |